Pfizer
As Chief Global Supply Officer, Executive Vice President, Mike McDermott leads all of Pfizer’s internal and external manufacturing and supply chain activities.
Mike and the Pfizer Global Supply (PGS) team work to ensure uninterrupted supply for Pfizer’s entire product portfolio, which includes hundreds of medicines and vaccines – more than 38 billion doses each year. The PGS network includes approximately 30,000 colleagues and contractors and 39 Pfizer global manufacturing sites.
Recent highlights include the rapid ramp-up of manufacturing and global distribution of the Pfizer-BioNTech COVID-19 vaccine; ongoing efforts to enhance COVID-19 vaccine production and distribution processes; and the expedited production of Pfizer’s novel COVID-19 oral antiviral.
Mike has more than 30 years of experience in the pharmaceutical industry and has held positions in all aspects of supply operations as well as in Marketing and Finance. He joined Wyeth in 1989 as a Project Engineer in Pearl River, New York. Mike returned to Pearl River in 2003 as the site’s Managing Director for Vaccines manufacturing and was elevated to the role of Vice President of Site Operations in 2007.
With Pfizer’s acquisition of Wyeth in 2009, Mike became leader of the Consumer Healthcare Operating Unit and then was named Vice President of the Biotechnology Unit in 2012. In 2014, Mike became Vice President of Global Supply Chain, overseeing internal and external supply as well as distribution. He was named President of PGS in 2018 and assumed his current role in January 2022.
A passionate advocate for Diversity, Equity and Inclusion, Mike served on the Board of People to People, a non-profit organization that helps under-served people, for 10 years, and has enacted impactful changes to increase diversity within PGS. Mike, his wife Katie and their five daughters, of whom Mike is incredibly proud, are all committed to community engagement and social action.
Mike has Bachelor of Science and Master of Science degrees in Industrial Engineering from the New Jersey Institute of Technology (NJIT) in Newark, New Jersey. He has been an adjunct professor at NJIT and was named a distinguished alumnus. Mike serves on the Executive Committee of the National Association of Manufacturers and is a member of the Pharmaceutical Manufacturers Forum as well.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.